Risks, Side Effects, and Safety Considerations Peptide therapy carries real, still-incompletely-understood risks, and safety should be the first question anyone asks before considering it
Learn more Explore Weight Loss in Depth Frequently Asked Questions What are lipotropic injections made of
Bibcode:2011ChEuJ..1710151H
TB-500 and Thymosin Beta-4 are also prohibited by WADA/USADA under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), applicable at all times both in-competition and out-of-competition TB-500 / Thymosin Beta-4 Clinical Trials: The RGN-352 and RGN-259 Programs RegeneRx Biopharmaceuticals has pursued two clinical development programs for Thymosin Beta-4, providing the most substantial human clinical data available for any TB-500-related compound: RGN-352 (Injectable Thymosin Beta-4 for Cardiac Repair): Phase 1 trial (completed): A double-blind, placebo-controlled study enrolled 40 healthy volunteers across four cohorts of 10 subjects each, testing escalating dose levels of intravenous Thymosin Beta-4 administered daily over 14 days
Here are the genuine clinical reasons, what is normal, and the warning signs that mean you should see a doctor